Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery

Next Previous
Search
Trial Profile

Use of 48 Hour Course of Antibiotics to Prevent Surgical Site Infection in Obese Patients Undergoing Cesarean Delivery

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 09 Oct 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cefalexin (Primary) ; Metronidazole (Primary) ; Cephalosporins
  • Indications Bacterial infections; Postoperative infections
  • Focus Therapeutic Use

Most Recent Events

  • 19 Sep 2017 Primary endpoint (Surgical site infection) has been met as per the results published in the JAMA: the Journal of the American Medical Association
  • 19 Sep 2017 Status changed from recruiting to completed as per the results published in the JAMA: the Journal of the American Medical Association
  • 19 Sep 2017 Results published in the JAMA: the Journal of the American Medical Association

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top